Literature DB >> 23625754

Thrombosis in nephrotic syndrome.

Biagio Barbano1, Antonietta Gigante, Antonio Amoroso, Rosario Cianci.   

Abstract

Nephrotic syndrome (NS) is characterized by heavy proteinuria, edema, hypoalbuminemia, and hyperlipidemia and the most frequent causes are glomerular diseases. An uncommon presentation is iatrogenic NS, an adverse effect of some drugs administration. In the clinical course of NS, a typical feature is dysregulated coagulation state, promoted by the breakdown of permselectivity barrier of the glomerular capillary wall, resulting in the leakage of high-molecular-mass proteins, at least the size of albumin. This hypercoagulable condition is supported by several factors, such as abnormalities in platelet activation and an imbalance between anticoagulation/antithrombosis and procoagulant/prothrombotic mechanisms. Thus, NS and the risk of developing thromboses are strictly related. Thrombotic events affect the venous system rather than arterial vessels with different features and frequencies. Deep venous system of the lower extremities and renal veins are the most frequent source of pulmonary embolism, the most dangerous NS complication. Prophylactic anticoagulation and thrombosis treatment are not clearly established because large randomized trials and guidelines are lacking. The management of NS and the decision of when and how to anticoagulate the patient represent a teamwork challenge for physicians. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23625754     DOI: 10.1055/s-0033-1343887

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  19 in total

1.  A case of IgA nephropathy with deep venous thrombosis in the mesentery and lower extremities.

Authors:  Hong Tang; Lei Zhang; Wei Zhao; Rongquan Chen; Min Xie
Journal:  Quant Imaging Med Surg       Date:  2018-12

2.  Evaluation of heart rate recovery in patients with primary nephrotic syndrome.

Authors:  N Ozkayar; S Akyel; F Dede; F Akyel; D Turgut; M Bulut; A R Odabaş
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

3.  Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Authors:  N C Olson; M Cushman; P L Lutsey; L A McClure; S Judd; R P Tracy; A R Folsom; N A Zakai
Journal:  J Thromb Haemost       Date:  2014-10-31       Impact factor: 5.824

4.  Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis.

Authors:  Fumiaki Obata; Hideharu Abe; Taichi Murakami; Sayo Ueda; Taizo Inagaki; Masanori Minato; Hiroyuki Ono; Kenji Nishimura; Eriko Shibata; Masanori Tamaki; Fumi Kishi; Seiji Kishi; Kojiro Nagai; Toshio Doi
Journal:  CEN Case Rep       Date:  2019-02-05

5.  Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome.

Authors:  Shi-jun Li; Yuan-Mao Tu; Chang-sheng Zhou; Li-Hua Zhang; Zhi-hong Liu
Journal:  Clin Exp Nephrol       Date:  2015-07-29       Impact factor: 2.801

6.  Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis.

Authors:  Katherine M Bever; Luke I Masha; Fangui Sun; Lauren Stern; Andrea Havasi; John L Berk; Vaishali Sanchorawala; David C Seldin; J Mark Sloan
Journal:  Haematologica       Date:  2015-10-09       Impact factor: 9.941

7.  Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study.

Authors:  Fabio Paglialonga; Andrea Artoni; Simon Braham; Silvia Consolo; Alberto Giannini; Giovanna Chidini; Luisa Napolitano; Ida Martinelli; Giovanni Montini; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2015-12-14       Impact factor: 3.714

8.  Anticoagulation in chronic kidney disease patients-the practical aspects.

Authors:  Stephen Hughes; Iren Szeki; Michael J Nash; Jecko Thachil
Journal:  Clin Kidney J       Date:  2014-08-02

9.  Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency.

Authors:  Andrea Artoni; Serena Maria Passamonti; Alberto Edefonti; Francesca Gianniello; Vittorio Civelli; Ida Martinelli
Journal:  Ital J Pediatr       Date:  2016-02-29       Impact factor: 2.638

10.  Choking the Feeder.

Authors:  M E Fernando
Journal:  Indian J Nephrol       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.